O
Omeros is a Seattle-based biopharmaceutical company committed to discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. Show more Show less
Investor insights
Funding rounds participated in
$4M sweet spot round size
Investor type
Public Company
Basic info
Industry
Biotechnology Research
Sectors
Biotechnology Research
Date founded
1994
Funding rounds raised
Total raised
$4M
from 1 investors over 1 rounds
O
Omeros Corporation raised $4M on April 13, 2025
Investors: National Institute on Drug Abuse (NIDA)